Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4101745, 11 pages
https://doi.org/10.1155/2017/4101745
Research Article

A Type III Effector NleF from EHEC Inhibits Epithelial Inflammatory Cell Death by Targeting Caspase-4

1State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Biotechnology, Beijing 100071, China
2Institute of Health Sciences, Anhui University, Hefei, Anhui 230601, China

Correspondence should be addressed to Hongguang Ren; moc.361@neroib, Junjie Yue; moc.621@eijeuj_euy, and Long Liang; nc.ca.imb@ll

Received 17 February 2017; Accepted 5 April 2017; Published 16 May 2017

Academic Editor: Yun-Peng Chao

Copyright © 2017 Ting Song et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. J. Schuijt, T. van der Poll, W. M. de Vos, and W. J. Wiersinga, “The intestinal microbiota and host immune interactions in the critically ill,” Trends in Microbiology, vol. 21, pp. 221–229, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Geremia, P. Biancheri, P. Allan, G. R. Corazza, and A. di Sabatino, “Innate and adaptive immunity in inflammatory bowel disease,” Autoimmunity Reviews, vol. 13, pp. 3–10, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. T. H. Mogensen, “Pathogen recognition and inflammatory signaling in innate immune defenses,” Clinical Microbiology Reviews, vol. 22, pp. 240–273, 2009. View at Publisher · View at Google Scholar
  4. H. Ashida, H. Mimuro, M. Ogawa et al., “Cell death and infection: a double-edged sword for host and pathogen survival,” Journal of Cell Biology, vol. 195, pp. 931–942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Weinrauch and A. Zychlinsky, “The induction of apoptosis by bacterial pathogens,” Annual Review of Microbiology, vol. 53, pp. 155–187, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Lamkanfi and V. M. Dixit, “Manipulation of host cell death pathways during microbial infections,” Cell Host Microbe, vol. 8, pp. 44–54, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Bergsbaken, S. L. Fink, and B. T. Cookson, “Pyroptosis: host cell death and inflammation,” Nature Reviews Microbiology, vol. 7, pp. 99–109, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Sotolongo, J. Ruiz, and M. Fukata, “The role of innate immunity in the host defense against intestinal bacterial pathogens,” Current Infectious Disease Reports, vol. 14, pp. 15–23, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. J. S. Pearson and E. L. Hartland, “The inflammatory response during enterohemorrhagic escherichia coli infection,” Microbiology Spectrum, vol. 2, Article ID EHEC-0012-2013, 2014. View at Google Scholar
  10. L. A. Knodler, S. M. Crowley, H. P. Sham, H. Yang, M. Wrande, C. Ma et al., “Noncanonical inflammasome activation of caspase-4/caspase-11 mediates epithelial defenses against enteric bacterial pathogens,” Cell Host Microbe, vol. 16, pp. 249–256, 2014. View at Google Scholar
  11. M. A. Croxen, R. J. Law, R. Scholz, K. M. Keeney, M. Wlodarska, and B. B. Finlay, “Recent advances in understanding enteric pathogenic Escherichia coli,” Clinical Microbiology Reviews, vol. 26, pp. 822–880, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Deng, J. L. Puente, S. Gruenheid, Y. Li, B. A. Vallance, A. Vazquez et al., “Dissecting virulence: systematic and functional analyses of a pathogenicity island,” Proceedings of The National Academy of Sciences of The United States of America, vol. 101, pp. 3597–3602, 2004. View at Google Scholar
  13. C. Hemrajani, C. N. Berger, K. S. Robinson, O. Marchès, A. Mousnier, and G. Frankel, “NleH effectors interact with Bax inhibitor-1 to block apoptosis during enteropathogenic Escherichia coli infection,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, pp. 3129–3134, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Kobayashi, M. Ogawa, T. Sanada, H. Mimuro, M. Kim, H. Ashida et al., “The Shigella OspC3 effector inhibits caspase-4, antagonizes inflammatory cell death, and promotes epithelial infection,” Cell Host Microbe, vol. 13, pp. 570–583, 2013. View at Google Scholar
  15. L. A. Knodler, B. B. Finlay, and O. Steele-Mortimer, “The Salmonella effector protein SopB protects epithelial cells from apoptosis by sustained activation of Akt,” Journal of Biological Chemistry, vol. 280, pp. 9058–9064, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. A. R. Wong, J. S. Pearson, M. D. Bright, D. Munera, K. S. Robinson, S. F. Lee et al., “Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements,” Molecular Microbiology, vol. 80, pp. 1420–1438, 2011. View at Google Scholar
  17. S. Li, L. Zhang, Q. Yao, L. Li, N. Dong, J. Rong et al., “Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains,” Nature, vol. 501, pp. 242–246, 2013. View at Google Scholar
  18. J. S. Pearson, C. Giogha, S. Y. Ong, C. L. Kennedy, M. Kelly, K. S. Robinson et al., “A type III effector antagonizes death receptor signalling during bacterial gut infection,” Nature, vol. 501, pp. 247–251, 2013. View at Google Scholar
  19. H. Yen, T. Ooka, A. Iguchi, T. Hayashi, N. Sugimoto, and T. Tobe, “Nlec, a type III secretion protease, compromises NF-kB activation by targeting p65/rela,” PLoS Pathogens, vol. 6, Article ID e1001231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Baruch, L. Gur-Arie, C. Nadler, S. Koby, G. Yerushalmi, Y. Ben-Neriah et al., “Metalloprotease type III effectors that specifically cleave JNK and NF-kappaB,” EMBO J, vol. 30, pp. 221–231, 2011. View at Google Scholar
  21. L. Zhang, X. Ding, J. Cui, H. Xu, J. Chen, Y. N. Gong et al., “Cysteine methylation disrupts ubiquitin-chain sensing in NF-kappaB activation,” Nature, vol. 481, pp. 204–208, 2012. View at Google Scholar
  22. M. A. Pallett, V. F. Crepin, N. Serafini, M. Habibzay, O. Kotik, J. Sanchez-Garrido et al., “Bacterial virulence factor inhibits caspase-4/11 activation in intestinal epithelial cells,” Mucosal Immunology, vol. 10, pp. 602–612, 2016. View at Publisher · View at Google Scholar
  23. F. Echtenkamp, W. Deng, M. E. Wickham et al., “Characterization of the NleF effector protein from attaching and effacing bacterial pathogens,” FEMS Microbiology Letters, vol. 281, pp. 98–107, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. K. A. Datsenko and B. L. Wanner, “One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, pp. 6640–6645, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Blasche, M. Mortl, H. Steuber, G. Siszler, S. Nisa, F. Schwarz et al., “The E. coli effector protein NleF is a caspase inhibitor,” PloS One, vol. 8, Article ID e58937, 2013. View at Google Scholar
  26. D. J. Fernandez and M. Lamkanfi, “Inflammatory caspases: key regulators of inflammation and cell death,” Biological Chemistry, vol. 396, pp. 193–203, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. W. C. Earnshaw, L. M. Martins, and S. H. Kaufmann, “Mammalian caspases: structure, activation, substrates, and functions during apoptosis,” Annual Review of Biochemistry, vol. 68, pp. 383–424, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. G. Sollberger, G. E. Strittmatter, M. Kistowska, L. E. French, and H. Beer, “Caspase-4 is required for activation of inflammasomes,” Journal of Immunology, vol. 188, pp. 1992–2000, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. B. K. Coombes, M. E. Wickham, M. Mascarenhas, S. Gruenheid, B. B. Finlay, and M. A. Karmali, “Molecular analysis as an aid to assess the public health risk of non-O157 shiga toxin-producing Escherichia coli strains,” Applied and Environmental Microbiology, vol. 74, pp. 2153–2160, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. Y. Zhang, C. Laing, M. Steele et al., “Genome evolution in major Escherichia coli O157:H7 lineages,” BMC Genomics, vol. 8, p. 121, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Nadiri, M. K. Wolinski, and M. Saleh, “The inflammatory caspases: key players in the host response to pathogenic invasion and sepsis,” Journal of Immunology, vol. 177, pp. 4239–4245, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. C. N. Casson, J. Yu, V. M. Reyes et al., “Human caspase-4 mediates noncanonical inflammasome activation against gram-negative bacterial pathogens,” Proceedings of The National Academy of Sciences of The United States of America, vol. 112, pp. 6688–6693, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Shi, Y. Zhao, Y. Wang et al., “Inflammatory caspases are innate immune receptors for intracellular LPS,” Nature, vol. 514, pp. 187–192, 2014. View at Google Scholar · View at Scopus